Signal #119261 · SEC 8-K

$TARS SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $TARS filing catalyst

Why did $TARS trigger an AI stock catalyst alert?

$TARS triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: -6.5/10). Headline: Tarsus Reports Q3 Sales of $194.6M, Net Loss Widens to $668.3M ($14.40/Share). Key points: - XDEMVY net product sales increased 64% YoY to $194.6M. - GAAP net loss widened sharply to $668.3M or $(14.40) per share, compared to $(12.6M) in Q3 2025. - Operating expenses rose sharply, driving cash and cash equivalents down to $136.5M.

How did $TARS stock react after the SEC filing?

After the SEC 8-K for $TARS, observed market reaction: T0 price $72.64. Past moves do not guarantee future results.

Where can I get real-time $TARS SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $TARS via Telegram and the VIP Web Terminal from €10/month.

$TARS

$TARS – Tarsus Reports Q3 Sales of $194.6M, Net Loss Widens to $668.3M ($14.40/Share)

Tarsus Pharmaceuticals, Inc.

2026-11-03 00:00:00 UTC · SEC 8-K · All $TARS

Unlocked archive · Analyzed in <2s at T0

Bearish AI Sentiment (-6.5 / 10)

XDEMVY net product sales increased 64% YoY to $194.6M.
GAAP net loss widened sharply to $668.3M or $(14.40) per share, compared to $(12.6M) in Q3 2025.
Operating expenses rose sharply, driving cash and cash equivalents down to $136.5M.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →